TI
AERI

Turner Investments’s Aerie Pharmaceuticals AERI Stock Holding History

Turner Investments’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,000
Closed -$97K – 72
2017
Q3 		$97K Buy
+2,000
New +$109K 0.44% 74
2017
Q2 		– Sell
-5,000
Closed -$227K – 297
2017
Q1 		$227K Buy
+5,000
New +$223K 0.15% 171

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Turner Investments's AERI Position: Q4 2017 in Review

Turner Investments sold out of Aerie Pharmaceuticals (AERI) in Q4 2017, closing a stake of 2,000 shares — an estimated $97K sold.

Turner Investments first reported a position in AERI in Q1 2017 and held it in 2 quarters. The position peaked at $227K in Q1 2017. 179 funds tracked by Wall St. Rank hold AERI as of Q4 2017.

  • Turner Investments reported no remaining Aerie Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Turner Investments sold 2,000 Aerie Pharmaceuticals shares in Q4 2017, an estimated $97K.
  • Turner Investments first reported a position in Aerie Pharmaceuticals in Q1 2017 and held it in 2 quarters.
  • Turner Investments's Aerie Pharmaceuticals position peaked at $227K in Q1 2017.
  • 179 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2017.

Based on Turner Investments's 13F filing for Q4 2017, filed 2 Feb 2018.